We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Showcases Multiple New IVD Solutions at AACC 2015

By LabMedica International staff writers
Posted on 28 Jul 2015
Siemens showcases a multidisciplinary portfolio of its latest in vitro diagnostic (IVD) workflow solutions and assays in one location—Booth 1409 at the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA).

Siemens Healthcare Diagnostics division of Siemens Healthcare (Erlangen, Germany) reveals its latest IVD solutions: in addition to featuring its portfolio of multidisciplinary solutions designed for use in hospital, reference, and physician office laboratories and near patients’ bedsides, the booth highlights how Siemens’ customers are achieving their clinical and workflow goals.

Image: Overview of the Siemens Healthcare Diagnostics Booth 1409 at the AACC 2015, showcasing a multidisciplinary portfolio of Siemens’ latest IVD workflow solutions and assays in one location (Image courtesy of Siemens Healthcare).
Image: Overview of the Siemens Healthcare Diagnostics Booth 1409 at the AACC 2015, showcasing a multidisciplinary portfolio of Siemens’ latest IVD workflow solutions and assays in one location (Image courtesy of Siemens Healthcare).

“Customers need a reliable partner who can help them achieve higher levels of operational efficiency while providing quality results that lead to optimal patient care,” said Michael Reitermann, CEO, Siemens Healthcare Diagnostics, “The solutions we are showcasing at this year’s AACC can help customers successfully achieve their workflow and clinical goals, regardless of the size of their operations or testing demands.”

One such example, the ADVIA Centaur XPT Immunoassay System1 is a high-throughput analyzer that enhances workflow to meet demands for reliable, rapid immunoassay testing. Recently FDA-cleared, this analyzer is designed to provide simple, continuous operation; accurate, timely results; and powerful, seamless connectivity including to Aptio Automation, the company’s flexible, track-based automation system.

Aptio Automation’s connectivity options include the ADVIA Chemistry XPT System—Siemens’ newest high-throughput chemistry analyzer, and the Sysmex CS-5100 System2 – a high-volume hemostasis analyzer. Siemens is the only single-source provider able to connect all four key laboratory disciplines—chemistry, immunoassay, hematology, and hemostasis—to the automation track.

Also at the booth is the Sysmex CS-2100i System2—a mid-volume benchtop hemostasis analyzer. Both the Sysmex CS-2100i System and Sysmex CS 5100 System utilize simultaneous multi-wavelength detection and first-to-market PSI technology to manage unsuitable coagulation samples (e.g., improperly filled sample tubes) for high-quality results.

Another new hemostasis offering on display—one for point-of-care (POC) testing—is the Xprecia Stride Coagulation Analyzer1. Winner of the Red Dot design award, this handheld system performs prothrombin time testing (PT/INR). In hematology, Siemens now offers to small and mid-sized laboratories the ADVIA 360 Hematology System3 ADVIA 560 Hematology System3 and ADVIA 560 AL Hematology System3 – they provide state-of-the-art testing capabilities and may be used as backup systems for larger labs.

The company’s leadership is also evidenced by its latest products in urinalysis, infectious disease and molecular testing, and customer education.

The CLINITEK AUWi PRO Automated Urinalysis System4 is a walkaway solution for integrated urinalysis testing. It combines a urine chemistry analyzer (CLINITEK Novus Automated Urine Chemistry Analyzer) with a urine sediment analyzer (Sysmex UF-1000i Automated Urine Particle Analyzer).

New infectious disease assays include the ADVIA Centaur HIV Ag/Ab Combo (C-HIV) assay, which allows for sensitive and specific detection of HIV p24 antigen and antibodies and may improve detection of early acute infections. The ADVIA Centaur Syphilis assay is used as a diagnostic aid, allowing for sensitive and specific detection of antibodies to Treponema pallidum in human serum or plasma (EDTA, lithium or sodium heparinized, sodium citrate).

In molecular testing, experts will be on hand to discuss the automated Siemens Tissue Preparation Solution, a reproducible and standardized process for the extraction of high-quality nucleic acid from formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissues. It is enabling technology for the next generation of molecular diagnostics, including next-generation sequencing (NGS) for infectious disease and oncology testing.

Another innovative offering making its debut at AACC is Siemens PEPconnect, part of the total Personalized Education Plan (PEP)5, the industry’s first personalized learning and performance experience for healthcare professionals and their workgroup communities. With optimized technology and increased search capabilities, PEPconnect enables to access education and real-time performance support almost anytime, anywhere, and on almost any device, including smartphones.

At AACC, Siemens also offers educational workshops on chronic kidney disease and Centers for Disease Control (CDC) recommendations for syphilis and hepatitis C testing.

Related Links:

Siemens Healthcare at AACC 2015
Siemens Healthcare at AACC 2015, featured products
American Association for Clinical Chemistry (AACC)



New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Vitamin B12 Test
CHORUS CLIA VIT B12
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Latest AACC 2015 News

Automated Molecular Diagnostics System Presented at AACC 2015

Portable Molecular Diagnostics System Unveiled At 2015 AACC

Expanded Steroid Control Launched at the 2015 AACC Annual Meeting